These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Altered sialyl- and fucosyl-linkage on mucins in cystic fibrosis patients promotes formation of the sialyl-Lewis X determinant on salivary MUC-5B and MUC-7. Shori DK; Genter T; Hansen J; Koch C; Wyatt H; Kariyawasam HH; Knight RA; Hodson ME; Kalogeridis A; Tsanakas I Pflugers Arch; 2001; 443 Suppl 1():S55-61. PubMed ID: 11845304 [TBL] [Abstract][Full Text] [Related]
5. Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis. Dauletbaev N; Viel K; Buhl R; Wagner TO; Bargon J J Cyst Fibros; 2004 Jun; 3(2):119-24. PubMed ID: 15463894 [TBL] [Abstract][Full Text] [Related]
6. MUC5AC and MUC5B mucins increase in cystic fibrosis airway secretions during pulmonary exacerbation. Henke MO; John G; Germann M; Lindemann H; Rubin BK Am J Respir Crit Care Med; 2007 Apr; 175(8):816-21. PubMed ID: 17255563 [TBL] [Abstract][Full Text] [Related]
7. Extracellular pH and lung infections in cystic fibrosis. Massip-Copiz MM; Santa-Coloma TA Eur J Cell Biol; 2018 Aug; 97(6):402-410. PubMed ID: 29933921 [TBL] [Abstract][Full Text] [Related]
8. Mucus structure and properties in cystic fibrosis. Rubin BK Paediatr Respir Rev; 2007 Mar; 8(1):4-7. PubMed ID: 17419972 [TBL] [Abstract][Full Text] [Related]
9. Peroxidase activity within circulating neutrophils correlates with pulmonary phenotype in cystic fibrosis. Garner HP; Phillips JR; Herron JG; Severson SJ; Milla CE; Regelmann WE J Lab Clin Med; 2004 Sep; 144(3):127-33. PubMed ID: 15454881 [TBL] [Abstract][Full Text] [Related]
10. Increased levels of mucins in the cystic fibrosis mouse small intestine, and modulator effects of the Muc1 mucin expression. Malmberg EK; Noaksson KA; Phillipson M; Johansson ME; Hinojosa-Kurtzberg M; Holm L; Gendler SJ; Hansson GC Am J Physiol Gastrointest Liver Physiol; 2006 Aug; 291(2):G203-10. PubMed ID: 16500918 [TBL] [Abstract][Full Text] [Related]
11. Biochemical properties of tracheobronchial mucins from cystic fibrosis and non-cystic fibrosis individuals. Rose MC; Brown CF; Jacoby JZ; Lynn WS; Kaufman B Pediatr Res; 1987 Nov; 22(5):545-51. PubMed ID: 3684381 [TBL] [Abstract][Full Text] [Related]
12. Abnormal mucus: nominated but not yet elected. Forstner J; Wesley A; Mantle M; Kopelman H; Man D; Forstner G J Pediatr Gastroenterol Nutr; 1984; 3 Suppl 1():S67-73. PubMed ID: 6389816 [TBL] [Abstract][Full Text] [Related]
13. Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients. Khatri IA; Bhaskar KR; Lamont JT; Sajjan SU; Ho CK; Forstner J Pediatr Res; 2003 Apr; 53(4):619-27. PubMed ID: 12612214 [TBL] [Abstract][Full Text] [Related]
14. Comparison of physicochemical properties of purified mucus glycoproteins isolated from respiratory secretions of cystic fibrosis and asthmatic patients. Chace KV; Flux M; Sachdev GP Biochemistry; 1985 Dec; 24(25):7334-41. PubMed ID: 3002452 [TBL] [Abstract][Full Text] [Related]
15. Reduced thioredoxin increases proinflammatory cytokines and neutrophil influx in rat airways: modulation by airway mucus. Rancourt RC; Lee RL; O'Neill H; Accurso FJ; White CW Free Radic Biol Med; 2007 May; 42(9):1441-53. PubMed ID: 17395017 [TBL] [Abstract][Full Text] [Related]
16. Host mucin glycosylation plays a role in bacterial adhesion in lungs of individuals with cystic fibrosis. Venkatakrishnan V; Packer NH; Thaysen-Andersen M Expert Rev Respir Med; 2013 Oct; 7(5):553-76. PubMed ID: 24138697 [TBL] [Abstract][Full Text] [Related]
17. Evidence for airway surface dehydration as the initiating event in CF airway disease. Boucher RC J Intern Med; 2007 Jan; 261(1):5-16. PubMed ID: 17222164 [TBL] [Abstract][Full Text] [Related]
18. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease. Mall MA Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118 [TBL] [Abstract][Full Text] [Related]